Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in a Korean Community Hospital: In Vitro Activity of Ceftazidime-Avibactam and Other Agents

The novel antibiotic ceftazidime-avibactam was introduced in Korea in 2023. This study evaluated the in vitro susceptibility of Pseudomonas aeruginosa isolates from a community-based hospital to various antibiotics, including ceftazidime-avibactam. A total of 100 non-duplicated consecutive P. aerugi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lee Hyo-Jin, Cho Sung-Yeon, Lee Dong-Gun, Park Chulmin, Byun Jihyun, Chun Hye-Sun, Kim Yang Ree
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Sciendo 2025-12-01
Edice:	Polish Journal of Microbiology
Témata:	pseudomonas aeruginosa avibactam ceftazidime drug resistance residence characteristics
On-line přístup:	https://doi.org/10.33073/pjm-2025-045
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!